- Home
- LVO vs BRNS Comparison
LVO vs BRNS Comparison
Compare LVO & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LVO | BRNS |
|---|---|---|
| Founded | 2009 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.9M | 55.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | LVO | BRNS |
|---|---|---|
| Price | $4.41 | $0.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.00 | $4.00 |
| AVG Volume (30 Days) | ★ 123.6K | 69.0K |
| Earning Date | 02-12-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $86,702,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $28.01 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $3.92 | $0.64 |
| 52 Week High | $16.00 | $2.92 |
Technical Indicators
Market Signals| Indicator | LVO | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 43.13 | 41.43 |
| Support Level | $3.94 | $0.68 |
| Resistance Level | $5.29 | $0.74 |
| Average True Range (ATR) | 0.42 | 0.06 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 29.68 | 48.02 |
Price Performance
Historical ComparisonAbout LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.